Date of event
Thursday, July 23, 2020 - 5:00 pm -
Thursday, July 23, 2020 - 6:00 pm
Continuing Education Credits
None
Add to Calendar 2020-07-23 17:00:00 2020-07-23 18:00:00 Webinar: AASLD-NASPGHAN-SPLIT COVID-19 & the Liver: Pediatric Perspective Speakers Jaime Chu, MD, Mohit Kehar, MD, Noelle Ebel, MD, Burnett "Beau" S. Kelly, MD, and moderators Nadia Ovchinsky, MD, MBA, and Emily J. Rothbaum Perito, MD will help the pediatric hepatology community to understand the liver manifestations in children with SARS-COV2 infection and Multi-System Inflammatory Syndrome in children (MIS-C), and then take questions during a live Q&A. Registration is complimentary. AASLD alonzo.tolver@boldrstrategy.com America/New_York public

Content Contributors

AASLD COVID-19 Clinical Oversight Subcommittee

AASLD Pediatric Liver Disorders SIG

North American Society for Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN)

Society of Pediatric Liver Transplantation (SPLIT)

Presenters

  • Jaime Chu, MD
    Icahn School of Medicine at Mount Sinai
  • Mohit Kehar, MD
    Queen’s University School of Medicine
  • Noelle Ebel, MD
    Stanford University
  • Burnett "Beau" S. Kelly, MD
    DCI Donor Services Inc.

Moderator

  • Nadia Ovchinsky, MD, MBA
    Children's Hospital at Montefiore
  • Emily J. Rothbaum Perito, MD
    University of California, San Francisco

Panelists

  • TBD
  • TBD

Details

As the COVID-19 pandemic continues to evolve, it is important for the pediatric hepatology community to understand the liver manifestations in children with SARS-COV2 infection and Multi-System Inflammatory Syndrome in children (MIS-C). In addition, there may be unique susceptibilities in children with chronic liver disease and liver transplantation.

Participants will be able to:

  • Understand liver involvement in SARS-COV2 infection and MIS-C
  • Improve care for children with chronic liver disease and pediatric liver transplant recipients
  • Develop strategies for safe re-entry to clinical practice in pediatric hepatology and transplantation

Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, July 21, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.

Moderator Bio

Nadia Ovchinsky, MD, MBA

Nadia Ovchinsky, MD, MBA is the Director of Pediatric Hepatology, Medical Director of Pediatric Liver Transplantation, and an Associated Professor of Pediatrics at Albert Einstein College of Medicine - Children's Hospital at Montefiore. She trained in Pediatrics, Pediatric Gastroenterology, and Pediatric Hepatology at Columbia University Medical Center.

Dr. Ovchinsky’s research interests involve improving quality and enhancing the delivery care for children with chronic liver disorders, as well as optimizing long-term outcomes of pediatric liver transplantation. Dr. Ovchinsky is a member of Practice Metrics Committee, Vice Chair of Pediatric SIG Communications Committee, and a Pediatric SIG Liaison for NASPGHAN Professional Education Committee.

Photo of Nadia Ovchinsky, MD, MBA